T1	Participants 103 176	patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud
T2	Participants 440 514	nifedipine SR group (Group N) or the Ginkgo biloba extract group (Group G)
T3	Participants 716 737	Ninety-three subjects
T4	Participants 1137 1148	RP patients
